Vicapsys Life Sciences, Inc. SEC filings VICP
Vicapsys Life Sciences, Inc. has 92 filings in SEC EDGAR's recent list, going back to Jul 17, 2009. Its latest annual report, Form 10-K, was filed on Oct 21, 2024 for the period ended Dec 31, 2023. The latest quarterly report (Form 10-Q) was filed on Jan 10, 2025, covering the quarter ended Sep 30, 2024. The most recent current report (Form 8-K) was filed on Dec 27, 2023 (material agreement, new debt). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 21, 2025 | — |
| 3 | Initial insider ownership | Mar 21, 2025 | Apr 20, 2020 |
| 4 | Insider transaction | Sep 8, 2010 | Sep 3, 2010 |
| 4 | Insider transaction | Aug 16, 2010 | Aug 9, 2010 |
| SC 13G | Ownership over 5% (passive) | May 20, 2010 | — |
| 3 | Initial insider ownership | May 20, 2010 | May 13, 2010 |
| 4/A | Filing | Jan 29, 2010 | Jan 26, 2010 |
| 4 | Insider transaction | Jan 25, 2010 | Jan 17, 2010 |
| SC 13D | Ownership over 5% (active) | Dec 22, 2009 | — |
| 3/A | Filing | Dec 14, 2009 | Dec 8, 2009 |
| SC 13D | Ownership over 5% (active) | Dec 10, 2009 | — |
| 3 | Initial insider ownership | Dec 9, 2009 | Dec 8, 2009 |
| 3 | Initial insider ownership | Dec 9, 2009 | Dec 8, 2009 |
| 3 | Initial insider ownership | Dec 9, 2009 | Dec 8, 2009 |
| 3 | Initial insider ownership | Dec 9, 2009 | Dec 8, 2009 |
| 3 | Initial insider ownership | Dec 9, 2009 | Dec 8, 2009 |
| 3 | Initial insider ownership | Dec 9, 2009 | Dec 8, 2009 |
| 3 | Initial insider ownership | Dec 9, 2009 | Dec 8, 2009 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VICP (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Cumming, GA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1468639
- Former names
- SSGI, INC. (until Nov 7, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.